Objective To investigate the phenotype and function of CD4+ T cells in synovial fluid (SF)
from the affected joints of children with oligoarticular‐onset juvenile idiopathic arthritis (JIA), …

Objective To compare the efficacy and safety of adalimumab versus infliximab in an open‐label
prospective, comparative, multicenter cohort study of childhood noninfectious chronic …

Background In 2012, a European initiative called Single Hub and Access point for pediatric
Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic …

OBJECTIVES: To analyze whether there were clinical differences between genetically
positive and negative patients fulfilling periodic fever, aphthous stomatitis, pharyngitis, and …

Objective. To evaluate safety and efficacy of adalimumab (ADA) and infliximab (IFX) for the
treatment of juvenile idiopathic arthritis-related anterior uveitis (JIA-AU). Methods. Starting …

Background There is mounting evidence on the existence of a Pediatric Inflammatory
Multisystem Syndrome-temporally associated to SARS-CoV-2 infection (PIMS-TS), sharing …

Objective To assess the long-term efficacy and safety of infliximab plus methotrexate in
juvenile rheumatoid arthritis (JRA). Methods Patients eligible for the open-label extension (OLE, …

Objective. To summarize evidence regarding the effectiveness of MTX in the treatment of
childhood autoimmune chronic uveitis (ACU). Methods. A systematic search of articles between …

Objective To report on the clinical response to canakinumab in a patient with sporadic
nucleotide‐binding oligomerization domain–containing protein 2 (NOD‐2)–associated pediatric …

The study objective was to report treatment with an interleukin (IL)-1 receptor antagonist,
anakinra, in patients with multiorgan Behcet's disease (BD). Comparison of clinical …